Comparison of neoadjuvant chemotherapy versus upfront surgery with or without chemotherapy for patients with clinical stage III esophageal squamous cell carcinoma-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Comparison of neoadjuvant chemotherapy versus upfront surgery with or without chemotherapy for patients with clinical stage III esophageal squamous cell carcinoma

Published:2016-02 Issue: Volume: Page:n/a-n/a
ISSN:1120-8694
Container-title:Diseases of the Esophagus
language:en
Short-container-title:Diseases of the Esophagus

Author:

Matsuda S.¹,Tsubosa Y.¹,Sato H.²,Takebayashi K.¹,Kawamorita K.¹,Mori K.³,Niihara M.¹,Tsushima T.⁴,Yokota T.⁴,Onozawa Y.⁴,Yasui H.⁴,Takeuchi H.⁵,Kitagawa Y.⁵

Affiliation:

1. Division of Esophageal Surgery; Shizuoka Cancer Center Hospital

2. Division of Upper Gastrointestinal Tract, Department of Surgery; International Medical Center, Saitama University

3. Clinical Trial Coordination Office

4. Division of Gastrointestinal Oncology; Shizuoka Cancer Center Hospital

5. Department of Surgery; Keio University School of Medicine

Publisher

Oxford University Press (OUP)

Subject

Gastroenterology,General Medicine

Link

http://academic.oup.com/dote/article-pdf/30/2/1/17727584/dote12473.pdf

Reference21 articles.

1. Preoperative chemoradiotherapy for esophageal or junctional cancer;Hagen;N Eng J Med,2012

2. 1 A randomized trial comparing postoperative adjuvant chemotherapy with cisplatin and 5-fluorouracil versus preoperative chemotherapy for localized advanced squamous cell carcinoma of the thoracic esophagus (JCOG9907);Ando;Ann Surg Oncol,2012

3. Pathologic nonresponders after neoadjuvant chemoradiation for esophageal cancer demonstrate no survival benefit compared with patients treated with primary esophagectomy;Dittrick;Ann Surg Oncol,2012

4. Induction therapy does not improve survival for clinical stage T2N0 esophageal cancer;Speicher;J Thorac Oncol,2014

5. Surgery alone versus chemoradiotherapy followed by surgery for stage I and II esophageal cancer: final analysis of randomized controlled phase III trial FFCD 9901;Mariette;J Clin Oncol,2014

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Does neoadjuvant therapy contribute to increased risk in anastomotic leakage of esophageal cancer? A network meta‐analysis;Journal of Evidence-Based Medicine;2024-08-19

2. Neoadjuvant Chemotherapy or Adjuvant Chemotherapy for Esophageal Squamous Cell Carcinoma;Annals of Surgical Oncology;2023-11-14

3. Neoadjuvant therapy combined with surgery is superior to chemoradiotherapy in esophageal squamous cell cancer patients with resectable supraclavicular lymph node metastasis: a propensity score-matched analysis;Annals of Translational Medicine;2022-03

4. Triple synchronous primary neoplasms in the gastrointestinal tract;Chinese Medical Journal;2021-02-03

5. Identification of a PLCE1‑regulated competing endogenous RNA regulatory network for esophageal squamous cell carcinoma;Oncology Reports;2021-01-04

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3